trending Market Intelligence /marketintelligence/en/news-insights/trending/ya6qg4peptv8flh8jgpcwg2 content esgSubNav
In This List

UniQure appoints 2 board members

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


UniQure appoints 2 board members

Amsterdam-based gene therapy company uniQure NV appointed Robert Gut and David Meek to the board.

Gut is currently the chief medical officer for Versartis Inc. Meek has been the CEO of Ipsen SA since 2016.